Celldex Therapeutics, Inc.

CLDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$67-$57-$54-$47
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$9$0$0
Change in WC$10$4-$8$7
Other Non-Cash$8-$2$7$6
Operating Cash Flow-$49-$44-$54-$32
Investing Activities
PP&E Inv.-$0-$1-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$56-$122-$152-$129
Inv. Sales/Matur.$117$173$195$154
Other Inv. Act.$0$0$0$0
Investing Cash Flow$61$50$43$24
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$1$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$13$6-$11-$8
Supplemental Information
Beg. Cash$23$17$28$36
End Cash$36$23$17$28
Free Cash Flow-$49-$45-$55-$33